THE INTERCEPT BLOOD SYSTEM FOR PLATELETS IS USED TO INACTIVATE A BROAD SPECTRUM OF VIRUSES, BACTERIA, PROTO…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT001423P0131
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $87,166
- Period of performance
- Jun 12, 2023 – Jun 18, 2024
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- MD
Public award description
THE INTERCEPT BLOOD SYSTEM FOR PLATELETS IS USED TO INACTIVATE A BROAD SPECTRUM OF VIRUSES, BACTERIA, PROTOZOA AND CONTAMINATING DONOR LEUKOCYTES IN PLATELET COMPONENTS.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Agency: Department of Defense
- PSC 6640 — Laboratory Equipment and Supplies
- Federal market intelligence software